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Abstract
Modifications in the subunit composition of AMPA receptors (AMPARs) have been 
linked to the transition from physiological to pathological conditions in a number 
of contexts, including EtOH-induced neurotoxicity. Previous work from our labora-
tory showed that EtOH withdrawal causes CA1 pyramidal cell death in organotypic 
hippocampal slices and changes in the expression of AMPARs. Here, we investi-
gated whether changes in expression and function of AMPARs may be causal for 
EtOH-induced neurotoxicity. To this aim, we examined the subunit composition, lo-
calization and function of AMPARs in hippocampal slices exposed to EtOH by using 
western blotting, surface expression assay, confocal microscopy and electrophysiol-
ogy. We found that EtOH withdrawal specifically increases GluA1 protein signal in 
total homogenates, but not in the post-synaptic density-enriched fraction. This is 
suggestive of overall increase and redistribution of AMPARs to the extrasynaptic 
compartment. At functional level, AMPA-induced calcium influx was unexpectedly 
reduced, whereas AMPA-induced current was enhanced in CA1 pyramidal neurons 
following EtOH withdrawal, suggesting that increased AMPAR expression may lead 
to cell death because of elevated excitability, and not for a direct contribution on cal-
cium influx. Finally, the neurotoxicity caused by EtOH withdrawal was attenuated by 
the non-selective AMPAR antagonist 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]
quinoxaline-7-sulfonamide disodium salt as well as by the selective antagonist of 
GluA2-lacking AMPARs 1-naphthyl acetyl spermine. We conclude that EtOH neuro-
toxicity involves changes in expression, surface localization and functional properties 
of AMPARs, and propose GluA2-lacking AMPARs as amenable specific targets for 
the development of neuroprotective drugs in EtOH-withdrawal syndrome.
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1  | INTRODUC TION
Ethanol (EtOH) abuse causes persistent structural and functional 
alterations in the brain by mechanisms that are not yet fully under-
stood. Many studies have shown permanent impairment in synaptic 
function and neuronal damage caused by EtOH exposure and with-
drawal in multiple neuronal areas, including the hippocampus, with 
both in vivo and in vitro models of neurotoxicity (Gerace et al., 2016, 
2019; Läck et al., 2007; Marty & Spigelman, 2012). AMPA receptors 
(AMPARs) mediate the fast component of excitatory neurotransmis-
sion, and the dynamic regulation of these receptors, both at tran-
scriptional and posttranscriptional level, is a crucial factor in the 
transition from physiological to pathological conditions. The homeo-
stasis of GluA1-2-containing AMPARs is controlled by several scaf-
fold and adhesion complex proteins that capture, retain and promote 
surface expression of AMPARs, thus, regulating physiological neuro-
nal functions and, in certain conditions, cell fate. AMPARs are local-
ized mostly in the postsynaptic density and their trafficking is tightly 
regulated by interactions with scaffold molecules controlling the dis-
tribution of AMPARs in the synaptic, intracellular and extrasynaptic 
pools (Newpher & Ehlers, 2008). Several AMPAR interacting pro-
teins have been identified, including glutamate receptor-interacting 
protein (GRIP) and protein interacting with C kinase-1 (PICK1), which 
have been shown to specifically interact with GluA2 subunit (Daw 
et al., 2000; DeSouza et al., 2002; Perez et al., 2001; Seidenman 
et al., 2003), the transmembrane protein stargazin, which interacts 
directly with AMPAR (Chen et al., 2000) and Synapse-associated 
protein 97 (SAP97), which specifically binds GluA1 subunit (Howard 
et al., 2010; Leonard et al., 1998).
Great attention has been focused on the GluA2 subunit as a 
result of its profound effects on AMPAR assembly, trafficking and 
ionic selectivity. A relative decrease in GluA2 subunit increases cal-
cium permeability of AMPARs, an event that has been linked to the 
transition from physiological to pathological conditions in a number 
of contexts. For example, one of the earliest biological manifesta-
tions of dementia in Alzheimer disease (AD) is owing to a reduction 
in synaptic AMPARs (Shankar et al., 2008). Moreover, prolonged de-
creases in surface GluA2-containing AMPARs have been described 
as a causal factor for cell death of hippocampal CA1 pyramidal neu-
rons in models of toxicity (Anzai et al., 2003; Gerace et al., 2014) 
and in pathological conditions including global ischemia (Pellegrini-
Giampietro, 1997). Interestingly, dysfunctional Q/R editing in 
GluA2 occurs in the motor neurons of patients with amyotrophic 
lateral sclerosis (ALS, Hideyama & Kwak, 2011). Calcium-permeable 
AMPARs (CpAMPARs) have also been demonstrated to play an es-
sential role in substance use disorders (SUD) models, as exposure 
to substances lead to AMPAR molecular switch and formation of 
CpAMPARs (Mameli et al., 2011; Pascoli et al., 2014). For example, 
it was recently shown that cocaine-induced potentiation of VTA 
excitatory synapses is mediated by the insertion of CpAMPARs to 
the synaptic membranes (Mills et al., 2017). Moreover, cadherin 
adhesion complex proteins have been shown to contribute to the 
stabilization of AMPARs into the synaptic membranes (Saglietti 
et al., 2007; Tai et al., 2008) and may contribute to the susceptibil-
ity to cocaine addiction by the stabilization of GluA1-2-containing 
AMPARs into synaptic membranes (Mills et al., 2017).
A recent paper from our laboratory has demonstrated that EtOH 
withdrawal induces cell death in mature organotypic hippocampal 
slices and that glutamate receptors are mediators of EtOH with-
drawal–induced toxicity (Gerace et al., 2019). In particular, we found 
that EtOH withdrawal increases the AMPA-mediated spontaneous 
excitatory postsynaptic currents (EPSCs) as well as the expression of 
GluA1 but not GluA2 AMPAR subunits, suggesting that the toxicity 
induced by EtOH withdrawal could be caused by the formation of 
GluA2-lacking, calcium-permeable AMPARs.
On the basis of these considerations, here we sought to inves-
tigate the role of GluA2-lacking AMPARs in the toxicity induced by 
EtOH withdrawal.
2  | MATERIAL S AND METHODS
Male and female Wistar rat pups (94 animals, 7–9 days old, weight 
16 ± 3 g) were obtained from Charles River. Animals were housed 
at 23 ± 1°C under a 12 hr light–dark cycle (lights on at 07:00) and 
were fed a standard laboratory diet with ad libitum access to water. 
The experimental protocols were approved by the Italian Ministry 
of Health (Aut. 176; 17E9C.N.VAS) and the European Communities 
Council Directive of 2010/63/EU.
The authors further attest that all efforts were made to minimize 
the number of animals used and their suffering, as reported in the 
Guidelines McGill Module-1. The present study was NOT pre-regis-
tered. NO subjects were excluded in the present study. No blinding 
for experiments was performed.
2.1 | Materials
Ethanol (EtOH, CAS No: 64-17-5), 1-Naphthylacetyl spermine 
trihydrochloride (NASPM, catalogue number: #N193) and pro-
pidium iodide (PI, CAS No: 25535-16-4) were purchased from 
Sigma. Tissue culture reagents were obtained from Gibco-BRL and 
Sigma. 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-
7-sulfonamide disodium salt (NBQX, catalogue number: #1044/1), 
tetrodotoxin Citrate (TTX, catalogue number: #1069), DL-2-Amino-
5-phosphonopentanoic acid (APV, catalogue number: #0105) and 
K E Y W O R D S
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pictotoxin (catalogue number: #1128) were purchased from Tocris. 
(R,S)-AMPA (CAS No: #74341-63-2) was purchased from Abcam.
2.2 | Preparation of rat organotypic hippocampal 
slice cultures
Organotypic hippocampal slice cultures were prepared as previously 
reported (Gerace et al., 2012, 2015; Landucci et al., 2018). Briefly, 
after decapitation hippocampi were isolated and removed from the 
brains of Wistar rat pups, transverse slices (420 µm) were prepared 
using a McIlwain tissue chopper and then transferred onto 30-mm-
diameter semi-porous membranes inserts (Millicell-CM, catalogue 
number: #PICM03050; Millipore), which were placed in six well tis-
sue culture plates containing 1.2-ml medium per well. Slices were 
maintained at 37°C in an incubator in an atmosphere of humidified 
air and 5% CO2 for 10 days. Before experiments all the slices were 
screened for viability by phase-contrast microscopy analysis; slices 
displaying signs of neurodegeneration were discarded from the 
study (exclusion criteria).
2.3 | Ethanol exposure and Drug Treatment 
in organotypic hippocampal slices
The experiments were conducted as previously described in Gerace 
et al. (2016) and Gerace et al. (2019). Briefly, hippocampal slice cul-
tures were exposed for 7 days to 150 mM of EtOH. The medium was 
changed every day adding EtOH to the fresh culture medium. For 
control slices, the medium was changed every day by adding fresh 
culture medium. After 7 days of EtOH treatment, some of the slices 
were incubated in EtOH fresh culture medium, EtOH-free medium 
or in EtOH-free medium plus the non-selective AMPA antagonist 
NBQX (10 µM) and the selective blocker of GluA2-lacking AMPARs 
NASPM (10 µM) for 24 hr before they were assessed for neuronal 
injury using PI fluorescence.
2.4 | Assessment of CA1 pyramidal cell injury
PI (5 μg/ml) was added to the medium either at the end of the 7-day 
EtOH incubation period or 24 hr after it was removed from the me-
dium. Thirty minutes later, fluorescence was viewed using an in-
verted fluorescence microscope (Olympus IX-50; Solent Scientific) 
equipped with a xenon-arc lamp, a low-power objective (4×) and 
a rhodamine filter. Images were digitized using a video image ob-
tained by a CCD camera (Diagnostic Instruments Inc.) controlled by 
software (InCyt Im1TM; Intracellular Imaging Inc.) and subsequently 
analysed using the Image-Pro Plus morphometric analysis software 
(Media Cybernetics). In order to quantify cell death, the CA1 hip-
pocampal subfield was identified and encompassed in a frame using 
the drawing function in the image software (ImageJ; NIH) and the 
optical density of PI fluorescence was detected. There was a linear 
correlation between CA1 PI fluorescence and the number of injured 
CA1 pyramidal cells as detected by morphological criteria (Pellegrini-
Giampietro et al., 1999).
2.5 | Western blot analysis
The experiments were conducted as previously described in Gerace 
et al. (2015) and Gerace et al. (2019). Cultured slices were washed 
with cold 0.01 M PBS and dissolved in 1% SDS. Total protein lev-
els were quantified using the BCA (bicinchoninic acid) Protein Assay 
(catalogue number: # 23,225) (Pierce). Forty μg of proteins were 
resolved by electrophoresis on SDS-polyacrylamide gel and trans-
ferred onto nitrocellulose membranes using the transblot TURBO 
(Bio-Rad). Blots were probed overnight at 4°C with primary an-
tibodies, all diluted 1:1,000. Immunodetection was performed 
with secondary antibodies conjugated to horseradish peroxi-
dase. The reactive bands were detected using chemiluminescence 
(ECLplus; Euroclone). Quantitative analysis was performed using the 
QuantityOne analysis software (Bio-Rad).
2.6 | Fluorescence immunohistochemistry and 
quantitative analysis
At the end of experiments, the organotypic slices were harvested 
and fixed O/N in ice-cold paraformaldehyde, 4% in PBS buffer. The 
day after, slices were rinsed in PSB and placed for at least 2 days in 
18% sucrose in PBS. Immunostaining was performed with the free-
floating method reported in Lana et al. (2014). Day 1: Organotypic 
hippocampal slices were placed in a multiwell and washed 3 times 
for 5 min in PBS-TX, then blocked for 60 min with BB containing 
10% Normal Goat Serum. Slices were then incubated overnight at 
4°C under slight agitation with a combination of two different pri-
mary antibodies (anti-NeuN (catalogue number: #ABN78), 1:400; 
Millipore; GluA1-AMPA subunit (catalogue number: #AGC-004), 
1:100 or GluA2-AMPA subunit (catalogue number: #AGC-005), 
1:100 (Alomone Labs) dissolved in BB.
Day 2: Sections were incubated for 2 hr at room temperature 
in the dark with AlexaFluor 488-conjugated donkey anti-rabbit IgG 
secondary antibody diluted in BB and then for 2 hr at room tem-
perature in the dark with AlexaFluor 488-conjugated donkey an-
ti-rabbit IgG (catalogue number: #A32790) secondary antibody 
plus AlexaFluor 555 goat anti-mouse (catalogue number: #A-21422; 
Invitrogen, Thermo Fisher) both diluted 1:400 in BB. After three 
washings, slices were mounted onto gelatin-coated slides using 
Vectashield hard set mounting medium with DAPI (catalogue num-
ber: #H-1200–10; Vector Laboratories).
Slices were observed under a LEICA TCS SP5 confocal laser scan-
ning microscope (Leica Microsystems CMS GmbH) equipped with a 
63× objective (z step of 0.3 µm). Confocal scans were acquired keeping 
all parameters constant. Image analyses were conducted on z-stacks 
projections which contained the region of interest, corresponding to 
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the CA1 area, using Image J (National Institute of Health, http://rsb.
info.nih.gov/ij). Quantification of GluA1 and GluA2 AMPA subunit im-
munoreactivity in CA1 was performed separately using Image J. Forty 
consecutive z-scans (0,3 µm each, total 12 µm) were stacked, starting 
at 10 µm inside the slice and an appropriate and constant threshold 
level was selected. Quantitation of immunofluorescence was then 
obtained from the ratio between positive pixels above threshold and 
total pixels in each region of interest.
2.7 | Real-time PCR for REST and GluA2 
mRNA expression
Real-time PCR was performed as previously reported in Llorente 
et al. (2015) and Lapucci et al. (2017). Total ribonucleic acid (RNA) 
was extracted using Trizol Reagent (catalogue number: #15596018; 
Life Technologies). Any contaminating DNA in the RNA samples was 
removed by incubation with DNase (Sigma Aldrich). Total RNA con-
centrations were determined using a NanoDrop ND-3300 spectro-
photometer (NanoDrop Technologies). Isolated RNA was maintained 
at 80°C until further processing. One µg of RNA was reverse tran-
scribed using iScript (Bio-Rad). Real-Time PCR was performed in dupli-
cate using Rotor-Gene 3,000 (Qiagen) and the Rotor-Gene TM SYBR® 
Green PCR Kit (Qiagen), the reactions were run at 95°C for 30 s, 95°C 
for 5 s and 60°C for 15 s for 45 cycles. As an internal control for nor-
malization, PCR reactions were performed concurrently with the am-
plification of a reference gene, 18S ribosomal RNA (rRNA).
The following primers were used:
REST: Forward primer (5'–3) 
GACGGAGAGCAAACCCAAGACCAG, Reverse primer (5′–3′) 
CTTGAGCCATCTCCGAGGAGGGTTC;
GluA2: Forward primer (5'–3') CCAAGGACTCGGGAAGTAAGG, 
Reverse primer (5′–3′) CCCCCGACAAGGATGTAGAA;
RNA 18S: Forward primer (5'–3') GATTAAGTGCCCTTTGTA, 
Reverse primer (5′–3′) GATCCGAGGGCCTCACTAAAC.
2.8 | Preparation of protein extracts and western 
blot analyses
Proteins from hippocampal slices were extracted as previously de-
scribed with minor modifications (Caffino et al., 2018; Fumagalli 
et al., 2008). Briefly, hippocampal slices were homogenized in a tef-
lon-glass homogenizer in cold 0.32 M sucrose buffer pH 7.4 contain-
ing 1 mM HEPES, 1 mM MgCl2, 1 mM NaHCO3 and 0.1 mM PMSF, 
in presence of commercial cocktails of protease (Roche) and phos-
phatase (Sigma-Aldrich) inhibitors and an aliquot of each homogen-
ate was then sonicated. The remaining homogenate was centrifuged 
at 13,000 g for 15 min obtaining a pellet. This pellet was resus-
pended in a buffer containing 75 mM KCl and 1% Triton X-100 and 
centrifuged at 100,000 g for 1 hr. The resulting pellet, referred as 
post-synaptic density (PSD) or Triton X-100 insoluble fraction (TIF), 
was homogenized in a glass–glass potter in 20 mM HEPES, protease 
and phosphatase inhibitors and stored at −20°C in presence of glyc-
erol 30%. Total proteins have been measured in the total homogen-
ate and in the TIF fraction according to the Bradford Protein Assay 
procedure (Bio-Rad Laboratories, Italy), using bovine serum albumin 
as calibration standard.
Equal amounts of proteins of the homogenate (6 µg) and of 
TIF fraction (5 µg) were run on criterion TGX precast gels (Bio-Rad 
Laboratories) under reducing conditions and electrophoretically 
transferred onto nitrocellulose membrane (Bio-Rad Laboratories). 
Blots were blocked 1 hr at room temperature with I-Block solu-
tion (catalogue number: # T2015, Life Technologies, Italia, Italy) in 
TBS + 0.1% Tween-20 buffer and incubated with antibodies against 
the proteins of interest.
The conditions of the primary antibodies were the following: 
anti N-Cadherin (catalogue number: #13116, 1:1,000; Cell Signaling 
Technology); anti mGluR5 (1:2000, Chemicon, USA); anti GRIP 
(catalogue number: #ABN27; 1:1,000; Sigma Aldrich); anti GluA1 
(catalogue number: #13185; 1:2000; Cell Signaling Technology); 
anti GluA2 (catalogue number: #13607; 1:1,000; Cell Signaling 
Technology); anti SAP97 (catalogue number: #ab2057181:1,000; 
Abcam); anti PSD-95 (catalogue number: #2507; 1:4,000, Cell 
Signaling Technology), anti β-catenin (catalogue number: # sc-7963; 
1:1,000, Santa Cruz Biotechnology) and anti β-Actin (catalogue num-
ber: # A5316; 1:10,000; Sigma-Aldrich). Results were standardized 
using β-actin as the control protein, which was detected by evaluat-
ing the band density at 43 kDa. Immunocomplexes were visualized 
by chemiluminescence using the Chemidoc MP Imaging System (Bio-
Rad Laboratories). Gels were run three times each and the results 
represent the average from three different western blots.
2.9 | Electrophysiological recordings
Whole-cell voltage-clamp recordings were performed in CA1 py-
ramidal neurons from organotypic hippocampal slices as previously 
described (Gerace et al., 2019). The slices were chronically treated 
with 150 mM of EtOH or under control conditions, followed by 
4–6 hr of EtOH withdrawal before recordings. A single slice was re-
moved from the culture insert, placed in a flow chamber positioned 
under the microscope objective and continuously perfused with 
warm (34–35°C) artificial Cerebrospinal Fluid (aCSF), composed of 
(in mM) 130 NaCl, 3.5 KCl, 1.25 NaH2PO4, 24 NaHCO3, 10 glucose, 
2 CaCl2 and 1 MgSO4 and saturated with a 95% O2 + 5% CO2 gas 
mixture. Whole-cell pipettes were pulled from thin-walled borosili-
cate capillaries (Harvard Apparatus) with a vertical puller (Narishige 
PP830, Narishige International Limited) back-filled with the follow-
ing intracellular solution (in mM): K+ Methanesulfonate (120), KCl 
(15), HEPES (10), EGTA (0.1), MgCl2 (2), Na2PhosphoCreatine (5), 
Na2GTP (0.3) and MgATP (2), resulting in a bath resistance of 3–5 
MΩ. For coupled recordings of electrical and fluorescent calcium 
signals, 0.1 mM of Fluo 4 pentapotassium salt (Molecular Probes) 
was added. Signals were sampled at 10 kHz and low-pass filtered at 
3 kHz with an Axon Multiclamp 700B (Molecular Devices, Sunnyvale, 
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CA, USA). After establishing a Giga-Ohm seal, a whole-cell configu-
ration was achieved by rupturing the neuronal membrane. Access 
resistance was monitored during voltage clamp recordings with brief 
test pulses (−10 mV, 500 ms), throughout the experiment. All data 
were analysed using pCLAMP (Axon Instruments) and GraphPad 
Software (San Diego, CA). AMPA-mediated electrical and optical re-
sponses were studied by obtaining sequences of 30 × 30-s record-
ing frames from individual CA1 neurons in whole-cell voltage clamp 
(VHOLDING = −65 mV) configuration. After the achievement of stable 
baselines, a mix of inhibitors was bath applied which included the 
voltage-dependent sodium channel blocker TTX (1 µM), the NMDA 
receptor antagonist DL-2-Amino-5-phosphonopentanoic acid (APV, 
50 µM) and the GABAA receptor antagonist picrotoxin (PTX, 50 µM). 
After 5 min, 0.3 µM AMPA was applied, in presence of inhibitors, in 
order to record pharmacologically isolated cellular responses.
2.10 | Microfluorometric determination of 
calcium responses
AMPA-induced calcium responses were studied as described in 
Carbone et al. (2017) with some modifications. During electro-
physiological recordings, fluorescence signal was collected from 
a square-shaped window comprising the cell body of the neuron 
under investigation loaded with 100 μM of the high-affinity, non-
ratiometric calcium dye Fluo 4 pentapotassium salt (Molecular 
Probes). Fluorescence was elicited with a 488 nm LED and collected 
with a photomultiplier tube (PMT; Cairns Research) with a 10 kHz 
sampling rate. LED excitation was triggered with the electrophysi-
ological protocol and consisted of 1 s of LED ON at the end of each 
30-s gap-free recording. Somatic calcium responses (SCRs) are re-
ported as ΔF/F0, where F0 signal was the baseline emission of the 
loaded neuron at rest, and ΔF was defined as FAMPA − F0 where FAMPA 
was taken at the end of AMPA application. Background fluorescence 
was obtained by measuring the emission of a Fluo 4-free area of the 
slice and subtracting the obtained value from F0. Off-line analysis 
was performed with Clampfit 10 (Molecular Devices) and Origin 9.1.
2.11 | Statistical analysis
Data are presented as means ± SEM of n experiments from independ-
ent cell preparations. Statistical significance of differences between 
PI fluorescence intensities, immunostaining or Western blot optical 
densities was evaluated by performing one-way ANOVA followed 
by Tukey's w test for multiple comparisons. For electrophysiological 
F I G U R E  1   Ethanol withdrawal induces changes in α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) subunit 
composition. Top: experimental protocol (a). Middle: representative Western blots using antibodies directed against the AMPAR subunit 
GluA1, GluA2 and GluA3 (b, c, d) and quantitative analysis of immunoreactive bands (e, f, g), showing that EtOH withdrawal increases the 
expression of the AMPA subunit GluA1. Tubulin was used as loading control. Bottom: analysis of the ratio between GluA1/GluA2, GluA1/
GluA3 and GluA3/GluA2 AMPA subunits expression in mature slices after chronic EtOH and EtOH withdrawal suggesting that EtOH 
withdrawal modifies AMPA subunit composition leading to GluA2-lacking and Ca2+-permeable AMPARs. Data are expressed as a percentage 
of control. Bars represent the mean ± SEMof at least five experiments from independent cell preparations (about ≥8 slices for each 
experimental point). *p < .05, **p< 0.1 versus. CRL and #p < .05 versus. Chronic EtOH (ANOVA + Tukey's test)
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experiments and determination of calcium response, statistical sig-
nificance was evaluated by performing a Student's t test for unpaired 
samples. Differences were considered significant for *p < .05, **p < .01 
and ***p < .001. All statistical calculations were performed using 
GRAPH-PAD PRISM v.5 for Windows (GraphPad Software). No sam-
ple calculation was performed to predetermine the sample size. Data 
were not assessed for normality. NO test for outliers was conducted.
3  | RESULTS
We used rat organotypic hippocampal slice cultures exposed to 
150 mM EtOH for 7 days (chronic) to mimic chronic EtOH consump-
tion and then we incubated the slices in EtOH-free medium for the 
subsequent 24 hr to mimic EtOH withdrawal in vitro. In these experi-
mental conditions, EtOH withdrawal led to a dose-dependent CA1 
F I G U R E  2   Ethanol withdrawal increases GluA1 AMPAR subunit expression in CA1 Stratum pyramidale of organotypic hippocampal 
slices. (a–b2) Representative confocal microscopy images showing CA1 immunostaining of neurons (NeuN, red, a1,b1), and GluA1-
AMPAR subunit (GluA1, green a2,b2) in CA1 pyramidal neurons of organotypic hippocampal slices in control (a–a2) or after 24h of EtOH 
withdrawal (b–b2). Scale bar: 10 μm. (c) Quantitative analysis of GluA1 immunoreactivity in CA1 Stratum pyramidale of control (CRL) 
(white column,n = 6), and EtOH-withdrawal slices (black column, n = 6) (**p < .05 EtOH withdrawal versus. CRL, Student'sttest). (c–d2) 
Representative confocal microscopy images showing CA1 immunostaining of neurons (NeuN, red, c1,d1), and GluA2 AMPAR subunit (GluA2, 
green, c2, d2) in CA1 Stratum pyramidale of organotypic hippocampal slices in control (c–c2) or after 24h of EtOH withdrawal (d–d2). Scale 
bar: 10 μm. (e): Quantitative analysis of GluA2 immunoreactivity in CA1 Stratum pyramidale of control (CRL) (white column, n = 4), and 
EtOH-withdrawal slices (black column, n = 3). The decrease was not statistically significant **p< 0.1 versus. CRL (Student's ttest)
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pyramidal cell injury examined using propidium iodide fluorescence 
as previously demonstrated and published (Gerace et al., 2016, 2019). 
With the aim to study the mechanism of EtOH-withdrawal toxicity, 
we firstly performed western blotting experiments to characterize 
the composition of AMPA receptor tetramers after EtOH withdrawal. 
We used specific antibodies directed against GluA1, GluA2 and GluA3 
AMPAR subunits (Figure 1a–c). We found that EtOH withdrawal in-
duced a significant increase in the expression of GluA1 (Figure 1a), 
no change was observed for GluA3 (Figure 1c), while a relative trend 
in a reduction was observed in the expression of GluA2 (Figure 1b) 
subunit. To this matter, the analysis of GluA1/GluA2 was significant 
after EtOH withdrawal as compared to control and to chronic EtOH 
and GluA3/GluA2 ratio expression was significant only versus con-
trol after EtOH withdrawal, while no changes was noticed for GluA1/
GluA3 ratio. These data suggest that EtOH withdrawal induces rel-
evant modification of AMPAR subunit composition leading to for-
mation of GluA2-lacking AMPARs (Figure 1d–f). We confirmed the 
data obtained by western blot analysis with immunofluorescence 
technique. Figure 2a shows that GluA1 expression is significantly 
increased while GluA2 appears to be decreased (Figure 2b) in CA1 
neurons after 24h of EtOH withdrawal compared to control slices. 
In order to elucidate the mechanisms of GluA2 lacking AMPA for-
mation, we considered another type of evidence resulting from the 
analysis of mRNA expression levels. In particular, we used real-time 
PCR to study the transcriptional repressor element-1 (RE1) silencing 
transcription factor (REST) gene, which was demonstrated to repress 
the transcription of GluA2 AMPAR subunit (Noh et al., 2012). The re-
sults showed that EtOH withdrawal induces the up-regulation of REST 
gene, conversely GluA2 mRNA gene was down-regulated (Figure 3), 
indicating that GluA2-lacking AMPARs formation could be caused by a 
transcriptional process. Furthermore, in order to study the trafficking 
of AMPARs, we measured the expression levels of GluA1 and GluA2 
in enriched postsynaptic membranes (PSD, Figure S1) under control, 
chronic EtOH or EtOH withdrawal (Figure 4). In contrast with the pre-
viously shown increase in GluA1 subunit in total homogenates, these 
data showed that EtOH down-regulates the expression of both GluA1 
and GluA2 AMPA subunits in PSD, suggesting that AMPARs should 
be relocated in the intracellular and/or extrasynaptic membrane com-
partments after EtOH treatment. Since cadherin adhesion complex 
proteins have been recently shown to contribute to the stabilization 
of GluA1/2-containing AMPARs into the synaptic membranes (Mameli 
et al., 2011; Mills et al., 2017), we analysed the levels of the scaffold 
proteins SAP97, GRIP and of N-cadherins in total homogenate and 
PSD preparations of organotypic slices under control, chronic EtOH 
or EtOH-withdrawal conditions (Figure 5). Our results showed that in 
total homogenate there is no modification of the expression level of the 
proteins examined in any experimental conditions. On the contrary, a 
clear reduction in their expression was present in PSD. Collectively, 
these results indicate that chronic EtOH induces profound alterations 
in the molecular composition and surface expression of AMPARs. 
We then sought evidence that EtOH-induced molecular rearrange-
ments result in increased calcium conductance through GluA2-lacking 
AMPARs. To directly test this hypothesis, we simultaneously meas-
ured electrophysiological and fluorescence calcium responses in-
duced by AMPA stimulation in organotypic hippocampal slices during 
EtOH-withdrawal and in control conditions. These experiments were 
performed during early withdrawal (4–6 hr), when neurons are still vi-
able and amenable to functional investigation. CA1 pyramidal neurons 
F I G U R E  3   Ethanol withdrawal induces the up-regulation of the transcriptional repressor element-1 (RE1) silencing transcription factor 
(REST). Real-time PCR assessed mRNA expression levels of REST and of the AMPA subunit GluA2 gene after 24h of EtOH withdrawal. Data 
are expressed as percentage of control protein levels (white column). Bars represent the mean ± SEMof four experiments from independent 
cell preparations (about ≥ 4 slices for each experimental point). *p < .05 versus. CRL (ANOVA + Tukey's w test)
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were individually loaded with the non-ratiometric calcium dye Fluo4 
and then AMPA-mediated electrical and fluorescence responses were 
elicited by agonist application. Our results show that AMPA reliably 
induces an inward cationic current in both controls and EtOH-treated 
slices. Moreover, both peak value and area under the curve (AUC) of 
AMPA-induced inward currents are significantly increased in CA1 
neuron after EtOH withdrawal compared to control slices (Figure 6). 
These findings confirm that the EtOH-dependent rearrangements 
in expression and localization of AMPARs that we observed lead to 
functional changes. Of note, the increase in AMPA current is reflec-
tive of an actual increase in current density, since no differences in 
whole-cell capacitance (a proxy for soma size) were observed be-
tween the two conditions (Figure S5). AMPA application also induced 
detectable elevations in intracellular calcium in both experimental 
groups but, quite unexpectedly, the magnitude of AMPA-induced cal-
cium transients was significantly smaller in CA1 neurons from EtOH-
treated slices compared to controls (Figure 6d). Our data suggest that 
GluA2-lacking AMPARs may lead to excitotoxicity and neuronal death 
by driving network hyperexcitability rather than by a direct contribu-
tion of GluA2-lacking AMPARs-mediated calcium influx. To selectively 
assess the contribution of GluA2-lacking AMPARs in EtOH-induced 
hyperexcitation, we tested the neuroprotective efficacy of 1-naph-
thyl acetyl spermine (NASPM), a selective blocker of GluA2-lacking 
AMPARs, to protect CA1 neurons from EtOH-withdrawal toxicity, 
compared to NBQX (a non-selective AMPA antagonist). Our data 
showed that incubation of NASPM (10 µM) during the 24h of EtOH 
withdrawal significantly attenuated EtOH withdrawal–induced injury 
as well as NBQX, suggesting that the neurotoxicity induced by EtOH 
withdrawal is largely mediated by GluA2-lacking AMPARs (Figure 7).
4 | DISCUSSION
We have recently demonstrated that EtOH withdrawal induces CA1 
pyramidal cell death in organotypic hippocampal slices. In our exper-
imental condition, EtOH neurotoxicity was largely prevented by the 
non-selective AMPAR blocker NBQX and preceded by an increase in 
the amplitude of spontaneous EPSCs and in GluA1/GluA2 expres-
sion ratio, thus, pointing to GluA2-lacking AMPARs and to AMPAR-
mediated calcium currents, as a possible death mechanism involved 
in EtOH toxicity (Gerace et al., 2019). Building on this hypothesis, 
we investigated the implication of AMPARs and, in particular of 
F I G U R E  4   EtOH induces a significant reduction in GluA1 and GluA2 AMPA receptor subunit expression in the postsynaptic densities 
(PSD). The experiments were conducted as described in Figure 1. Representative immunoblots showing that the main AMPA receptor 
subunits GluA1 (left panel) and GluA2 (right panel) are significantly decreased after chronic EtOH and EtOH-withdrawal treatment in 
the PSD of organotypic hippocampal slices. Data are expressed as percentage of control protein levels (white column). Bar represent the 
mean ± SEM of six experiments from independent cell preparations (about ≥ 12 slices for each experimental point). **p < .01 and *p < .05 
versus. CRL (ANOVA + Tukey's w test)
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GluA2-lacking AMPARs, in EtOH toxicity by using biochemistry, 
molecular biology, microscopy and physiology. We first examined 
the expression levels of the main AMPAR subunits (GluA1, GluA2, 
GluA3) in the total homogenate of hippocampal slices chronically 
exposed to EtOH for 7 days followed by 24-hr withdrawal. We 
found that EtOH withdrawal leads to a significant increase in overall 
GluA1, but not GluA2 and GluA3, expression, thus, pointing to an in-
crease in the number of functional AMPARs (Figure 1b). Additionally, 
the significant increase in GluA1/GluA2 ratio suggests the molecular 
switch to GluA2-lacking AMPARs (Figure 1e), in line with previous 
works (Acosta et al., 2012; Jin et al., 2014; Li et al., 2017). Remarkably, 
the switch to GluA2-lacking AMPARs has been implicated in the al-
terations associated with EtOH consumption, such as behavioural 
reinforcement (Mameli et al., 2011; Marty & Spigelman, 2012). In 
addition, it has been reported that repeated systemic administration 
of EtOH causes facilitation of LTP that is mediated by the insertion 
of AMPAR into the synaptic membrane and in a long-lasting increase 
in the GluA1 and GluA2 AMPAR subunits expression in the dorso-
medial striatum of rats (Wang et al., 2012).
In the attempt to reveal the mechanism underlying the formation 
of GluA2-lacking AMPARs, as a consequence of EtOH withdrawal, 
we examined the mRNA expression of REST gene, one of the re-
pressors involved in the regulation of the AMPAR subunit GluA2 
(Noh et al., 2012). The activation of REST is clinically relevant in a 
model of ischemic stroke in vivo where it was reported to bind a 
subset of transcriptionally responsive genes, including GluA2 (Noh 
et al., 2012). Consistently, we found that REST gene expression is 
significantly up-regulated as a consequence of withdrawal and, at 
the same time, GluA2 gene expression is significantly reduced.
In order to get further insights into the modulation of AMPAR 
expression and function, we investigated the proteins regulating the 
trafficking and localization of these receptors to the post-synapse. 
F I G U R E  5   Effects of EtOH withdrawal on glutamate receptor-interacting protein (GRIP), synapse-associated protein 97 (SAP97) and 
N-cadherin expression in the whole homogenate and post-synaptic densities (PSD). (a) Representative immunoblots showing that GRIP, 
SAP97 and N-cadherin proteins expression are significantly decreased after chronic EtOH and EtOH-withdrawal treatment in the PSD, but 
not in the homogenate of organotypic hippocampal slices. Panel (b) shows the protein levels of GRIP1 (upper panels), SAP97 (middle panels) 
and N-cadherin (lower panel). Data are expressed as percentage of control protein levels (white column). Bar represent the mean ± SEMof 
six experiments from independent cell preparations (about ≥12 slices for each experimental point). **p < .01 and *p < .05 versus. CRL 
(ANOVA + Tukey's w test)
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To this end, we examined the levels of GluA1 and GluA2, as well as 
scaffold proteins SAP97, GRIP, N-cadherin and beta catenin in total 
homogenate and PSD-enriched fractions from organotypic slices in 
control, chronic EtOH or EtOH withdrawal. We observed a clear re-
duction in the expression of all the proteins analysed (GRIP, SAP97, 
N-cadherin) in the PSD preparation. Together with the previously 
shown increase in GluA1 subunit in total homogenates, this result 
suggests a re-localization of AMPARs to extrasynaptic compart-
ments. The extrasynaptic distribution of AMPARs have particularly 
relevant consequences for synapse function and the lateral distri-
bution of AMPARs within the PSD provides an effective mecha-
nism for modulating synaptic strength (MacGillavry et al., 2011; 
Newpher & Ehlers, 2008). For example, hippocampal neurons 
exposed to TNF⍺ treatment display an increased surface level of 
AMPARs after 15 min, the majority of which are relocalized to ex-
trasynaptic sites. This mechanism has been proposed to contribute 
to excitotoxic neuronal death and is prevented by GluA2-lacking 
AMPAR antagonist NASPM (Leonoudakis et al., 2008), suggesting 
a role for AMPAR-mediated calcium in neurotoxicity. Functional 
determination of AMPA-induced calcium influx and whole-cell 
current during early EtOH withdrawal confirms that increased 
expression and subunit remodelling of AMPARs involve deep and 
complex changes at functional level. The most striking finding was 
that AMPA-induced, AMPAR-mediated calcium entry was reduced 
in CA1 neurons of EtOH-treated slices during early withdrawal. 
This result, which came unexpected, based on biochemical data, 
seems to exclude a direct involvement of AMPAR-mediated cal-
cium inflow in EtOH-withdrawal neurotoxicity. The paradoxical 
reduction in AMPA-induced calcium influx in presence of increased 
GluA2-lacking AMPAR levels is possibly caused by post-transla-
tional modulation (Ivanova et al., 2020), and requires further in-
vestigation which goes beyond the scope of the present study. In 
contrast, we found that AMPA-induced whole-cell currents in CA1 
neurons subject to EtOH withdrawal were enhanced. This is con-
sistent with the increased GluA1 levels and EPSCs amplitude that 
we previously reported in this model following EtOH withdrawal 
(Gerace et al., 2019). Furthermore, early single-channel recordings 
reported larger unitary conductance of GluA2-lacking AMPARs in 
heterologous expression systems (Swanson et al., 1997).
In light of these results, we propose increased network excit-
ability, promoted by simultaneous increase in AMPAR function and 
removal of EtOH-mediated potentiation of inhibition, as the main 
mechanism of EtOH excitotoxicity, in agreement with the protective 
effect exerted by AMPAR blockers. In this regard, the evidence that 
the non-selective blocker NBQX and the selective GluA2-lacking 
AMPAR blocker NASPM show equal neuroprotective action sug-
gests that, at molecular level, GluA2-lacking AMPARs are the main 
molecular entities accounting for the increased AMPA-induced cur-
rent and thereby potentially represent a specific target for the devel-
opment of neuroprotectants against the neurotoxic effects of EtOH 
withdrawal.
F I G U R E  6   Electrophysiological and fluorescence calcium 
responses induced by AMPA stimulation in organotypic 
hippocampal slices. (a) CA1 pyramidal cell filled with Fluo-4 
excited with blue LED light. (b) Experimental paradigm.Top: 
Electrophysiological protocol consisted of 30×, 30-s gap-free 
recordings.Middle and bottom: Optical protocol consisted of 1-s LED 
pulse and fluorescence collection with PMT at the end of each 30-s 
gap-free recording. (c)Top: time course of isolated AMPA current 
reported as average of “n” superimposed recordings ± SEM(gray 
shading) from CRL (left,n = 11) and EtOH-withdrawal group 
(right,n = 16).Bottom: quantification of AMPA-mediated current 
expressed as peak amplitude (left; CRL: −53.11 ± 6.38 pA,n = 11; 
EtOH withdrawal: −81.82 ± 8.58 pA,n = 16) and AUC (right; CRL: 
−1.51 ± 0.20 107pA·ms,n = 11; EtOH withdrawal: −2.20 ± 0.22 
107pA·ms,n = 16). (d)Top: averaged fluorescence responses 
to pulsed LED excitation before (F0) and after (FAMPA) agonist 
application, from CRL (left,n = 10) and EtOH-withdrawal group 
(right,n = 14). Scale bar,x = 500 ms,y = 0.2 ΔF/F0.Bottom: 
quantification of absolute ΔF/F0 (left, CRL: 0.11 ± 0.02,n = 11; 
EtOH withdrawal: 0.05 ± 0.01,n = 16) and ΔF/F0normalized to total 
AMPA current (right, CRL: −0.83 ± 0.19,n = 11; EtOH withdrawal: 
−0.23 ± 0.04,n = 16). All histograms report data as mean 
values ± SEMversus. CRL group. *p < .05 and **p < .01 versus. CRL 
group (Student'st-test)
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